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Abstract
Cardiovascular disease exerts a consistent force of morbidity and mortality on the global
population. This pressure has created a demand for reliable replacement vascular tissues. Current
solutions include synthetic grafts and biological transplant options that are associated with a
multitude of complications. Therefore, the continued innovation of vascular tissue replacement
solutions is warranted. Decellularized vascular tissues have been previously utilized as scaffolds
upon which recellularized tissue engineered vascular solutions are constructed. However the
interplay between decellularization agent concentration and effective recellularization has not
been well documented. Herein we investigate this relationship through a detail oriented research
model that both qualifies characteristic differences in decellularized tissues prepared in
heterogeneous detergent concentrations and quantifies endothelial cell responses to those
variations. In brief, seeding scaffolds were created from porcine internal thoracic arteries through
detergent based decellularized in five distinct decellularization detergent conditions. These
scaffolds were then seeded with endothelial cells using 3D printed seeding windows of our own
design. The results of these seeding trials were then evaluated metabolically and through
fluorescent microscopy. Additionally, a subset of scaffolds were exempted from seeding trials
and examined using scanning electron microscopy to determine detergent concentration effect on
scaffold ultrastructure. Results from the metabolic analysis of seeded scaffolds reveals a positive
correlation between decellularization detergent concentration and metabolic activity.
Additionally, cellular density and decellularization detergent concentration are also positively
correlated resulting in significant differences in cell density between detergent concentration
groups. However, detergent concentration did not affect the general cellularity of scaffold nor did
it cause consistent variation in scaffold ultrastructure.
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Introduction
1.1 Cardiovascular Disease
There is a consistent burden of morbidity resultant from cardiovascular disease. Synthetic
and biologically sourced valvular and vascular materials currently serve the needs of those
patients who require replacement cardiovascular tissues to remediate their conditions (Benjamin
et al. 2018). Both of these graft options come with severe limitations - implanted synthetic
materials never physiologically integrate with the graft recipient, while traditional allograft and
xenograft options require detrimental immunosuppression within the host in order to mitigate
harmful immune reactions to the tissue transplant recipient. These limitations make traditional
graft options unfeasible for many within the population who most need a solution - pediatric
patients suffering from congenital heart malformations and geriatric patients with degenerative
conditions (Meyer et al. 2005). Further, as the global population continues to grow, it is also
ageing (Population Prospects 2017). This global trend will accentuate the effects of heart disease
as older populations, regardless of ethnicity and sex, experience an increased risk of
cardiovascular complications. As such, the need for continued development of alternative and
innovative graft options is of tremendous relevance. Within this demand, there is a pronounced
lack of developed small and medium sized vascular implant options (Hausenloy and Yellon,
2013; Sun, Altalhi, and Nunes, 2015). The rapidly growing and maturing field of tissue
engineering has tremendous potential to fill this void.

1.2 Vascular Tissue Engineering
A succinct definition of tissue engineering could be given as the utilization of life
sciences and engineering principles in tandem towards the understanding and production of
biological, especially mammalian, structures including tissues and organs (Skalak R. & Fox CF.
1988). This approach is well suited to advance the development of both small and medium sized

2

vascular implants - complex tissues with demanding specific structural composition and diverse
physiological roles. Any potential implant solution must meet a high standard of usefulness. It
should be simple and quick to manufacture, not elicit a detrimental host immune response, not
increase patient susceptibility to infection, adequately perfuse tissues, and be exceedingly durable
as to not require re-operation (Duan, 2016; Meyer et al. 2005; Song et al. 2018). Creation of such
a graft might be achieved using decellularized vascular tissue as biological scaffolds for native
cells (Amiel et al. 2006). The creation of such an implant requires two sequential procedures: 1.)
the decellularization of scaffold material followed by 2.) the seeding of the decellularized scaffold
with the appropriate cell types prior to a quality control check and implantation into a patient.
Decellularization is the process by which the cellular components of a tissue are removed
while simultaneously preserving the extracellular matrix (ECM) (Crapo et al. 2011). Extracellular
matrices are an ideal foundation upon which to build a functional tissue for a variety of reasons.
First, building a tissue upon the ECM negates the need to replicate the complex processes that
prompt cells to deposit the ECM components (Badlyak et al. 2009). Further, the ECM contains
fibrous proteins (collagen, fibrin, elastin, and fibroin) and glycosaminoglycans (Hyaluronan,
Chondroitinsulfate, and Heparin) that are useful in the construction of biologically active tissues.
ECM proteins contribute to the tissues’ structural and mechanical integrity in conjunction with
glycosaminoglycans which contribute other physiological functions, such as heparin’s
anticoagulatory role (Celikkin et al. 2017). Decellularized tissues can be re-seeded with diverse
cell types both in vitro and in vivo (Amiel et al. 2006; Adndrée et al. 2014). In animal models, it
has been shown that the decellularized tissue itself elicits a reduced immune response compared
to allograft tissues upon implantation and is therefore a promising foundation on which to build
(Meyer et al. 2005).
The decellularization process has been documented in the tissue engineering literature in
many forms, and it may be accomplished through chemical, biological, and physical agents alike.
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The choice of a decellularization technique is dependent upon the composition of the starting
tissue and the desired material properties that must be met by the final product (Crapo et al.
2011). Of particular interest to this research are sodium dodecyl sulfate (SDS), sodium
deoxycholate (SDC), and DNase. SDS is a capable nonionic detergent used to remove nuclei
from tissues that may otherwise be impenetrable to decellularizing agents. SDS is also used to
remove cellular residue from partially decellularized tissues (though its use is sometimes
associated with ECM damage) (Crapo et al. 2011). SDC is also effective in achieving
decellularization but is less associated with ultrastructure damage (Kasimir et al. 2003). DNase is
a nuclease effective for removing DNA from lysed cells, which is crucial to further decreasing the
immunogenicity of decellularized tissues (Crapo et al. 2011; Seif-Naraghi et al. 2013). Each of
these agents is representative of larger classes of decellularizing agents - nonionic and ionic
detergents (SDS and SDC respectively) and enzymes (DNase). These classes of decellularizing
agents have been well documented as successful in producing viable tissue constructs eventually
repopulated by diverse cell lines (Amiel et al. 2006; Andrée et al. 2014; Lichtenberg et al. 2006;
Quinn et al. 2012).
The recellularization or “seeding” of decellularized scaffolds is, like decellularization, a
process that can be accomplished through several pathways. The goal of all seeding protocols and
systems is to repopulate the decellularized scaffold with the physiologically appropriate
composition of cells for the specific tissue being constructed. The methodology adopted in each
seeding process is therefore tissue specific to both the starting decellularized matrix, the cell
type(s) being used, and the end goal of the tissue construct. Reendothelialization of decellularized
constructs is of the utmost importance to the construction of a tissue engineered blood vessel
because a single layer of endothelial cells (ECs), anatomically referred to as the tunica intima,
coats the interior of both arteries and veins and is in direct contact with the blood.
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Reendothelialization has been previously achieved in decellularized scaffolds through
employment of bioreactor systems. These apparatus circulate cells through the decellularized
vessels at a low rate of flow and or in a pulsatile fashion and thereby evenly coat the interior of
the vessel with ECs through cellular adhesion interactions that cause some ECs to fall out of
solution and stick to the vessel wall (Andrée et al. 2014; Litchenburg et al. 2006). Others have
seeded scaffolds through a more passive approach wherein cells are suspended at a high
concentration and placed in direct static contact with the surface targeted for reendothelialization
(Amiel et al. 2006).
Amidst the research that has been done, there is a common lack of detailed in vitro
analysis of small diameter blood vessels constructed from decellularized extracellular matrix
scaffolds. Therefore, there is need for a detail driven and data oriented evaluation of both tissue
engineered material construction processes and of the resultant products. This study aims to
systematically characterize one such system. Specifically, the relationship between the detergent
concentration used for the decellularization of porcine internal thoracic arteries and the ability to
achieve reendothelialization of the scaffold with human cells was evaluated.

1.3 Rationale
Though much work has been done towards the goal of utilizing decellularized material as
a tissue engineered vascular implant solution, little has been published by way of data driven
analysis of methodologies within the decellularization and seeding processes. As such, basic
characterization of effective procedure within the systems of graft development and production
are important to furthering the vascular tissue engineering frontier. For this reason, my research
was oriented towards a detailed evaluation of the cell seeding efficacy of acellular scaffolds
created from porcine internal thoracic arteries. Specifically, I hypothesized that the concentration
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of the detergent agents used during the decellularization processes would govern the efficacy of
scaffold reendothelialization and effect scaffold ultrastructure.
Porcine arteries have been used in this study for three reasons. First, porcine arteries are
readily accessible as byproducts from slaughterhouses thus making their acquisition rapidly
achievable and inexpensive. Second, porcine internal thoracic arteries have similar physiologic
and mechanical properties and anatomical proportions to human coronary arteries. Third, porcine
arteries have been successfully decellularized and reseeded in previous studies (Andrée et al.
2014; Dahan et al. 2017; Amiel et al. 2006).

Materials and Methods
2.1 Cell Lines, Culture, and Handling
Telomerase (hTERT) immortalized human aortic endothelial cells, TeloHAEC
(American Type Culture Collection [ATCC] CRL 4052TM), were used as the source of
endothelial cells for all experiments (ATCC, Manassas, VA). This variant carries a ubiquitously
expressed GFP transgene, which allows for simple lineage tracing of the cells via fluorescent
microscopy. Cells were cultured per manufacturer recommendations. Briefly, cells were grown
on Falcon® 100mm TC-treated culture dishes (product number 353003) in vascular cell basal
medium (ATCC PCS-100-030) supplemented with endothelial cell growth kit-VEGF (ATCC
PCS-100-041) and 1-2% antibiotic antimycotic solution. Cells were incubated and allowed to
proliferate until approximately 90% confluence. These cells were then sub cultured for continued
growth.
Confluent cell plates utilized for seeding trials were trypsinized with 4mL of Thermo
Fischer Scientific 0.05% Trypsin-EDTA (catalogue number 25300054) for an interval of 5-10
min – exact trypsinization periods were tailored to ensure to full release (95-100%) of cells from
the culture plate (Thermo Fischer Scientific, Waltham, MA). Trypsin was neutralized with 4ml of
endothelial media. Subsequently, the cell suspension was transferred to a 50mL conical tube. A
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sample of this media was simultaneously taken for hemocytometer cell count analysis before the
cell suspension was centrifuged at a setting of 200 x g for 5 min. The media above the resulting
cellular pellet was then aspirated and the cells resuspended in media at a concentration of 1x10^6
cells per mL (as calculated using hemocytometer cell count gathered before centrifugation).

2.2 Scaffold Processing
After harvest, decellularization, and shipment by the laboratory of Dr. Wayne Carver
(University of South Carolina School of Medicine, Columbia, SC), porcine internal thoracic
artery scaffolds (PITAS) were received to our lab where final processing of the scaffold
(preparation for seeding) was completed. PITAS, regardless of their decellularization treatment
condition – Control/PBS, 0.5% SDS/SDC, 1% SDS/SDC, 1.5% SDS/SDC, and 3% SDS/SDC –
were subjected to the same processing protocols. First, one side of each PITA was cut along the
sagittal plane. This step served to open the native tubular structure of the artery into a planar
surface conformation. The flattened PITA was then further partitioned into as many pieces (≥
15mm x 15mm) as possible (Figure 1). These PITA sections were then advanced to the scaffold
sterilization and equilibration protocols.

Figure 1: Initial processing of PITA scaffolds. (A) One side of the tubular scaffold is cut along
the sagittal plane. Partitioning is indicated by red arrows and dashed line. (B) The opened scaffold
is sectioned into smaller portions. (C) Resultant pieces must be ≥ 15mm x 15mm in order to
correctly interface with the scaffold seeding window. Additionally, the bottom right corner of each
scaffold piece is cut off. Creation of this notch facilitates the correct orientation of the piece in
subsequent processes.
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The standard sterilization and equilibration protocol for decellularized PITAS consisted
of three steps. First, the scaffold was submerged in Betadine solution for 10 min with constant
agitation on an orbital shaker. Subsequently, the Betadine was aspirated and the scaffolds were
then rinsed in sterile 1X PBS for 10 intervals of 5 min. These sterilized and rinsed scaffolds were
then equilibrated in Corning® DMEM [+] 4.5 g/L glucose, L-glutamine, sodium pyruvate, and
1% antibiotic antimycotic for ≥ 20 min before use with seeding windows (Mediatech Inc.,
Manassas, VA).
The sterilization and equilibration protocol for scaffolds comprised of porcine acellular
muscle matrix (PAMM) involved four steps. First, the scaffold was rehydrated by submersion in
sterile 1X PBS for 1 h. Then, the scaffold was saturated in Betadine solution for 10 min with
constant agitation on an orbital shaker. Subsequently, the Betadine was aspirated and the
scaffolds were then rinsed in sterile 1X PBS for 10 intervals of 5 min. These sterilized and rinsed
scaffolds were then equilibrated in Corning® DMEM [+] 4.5 g/L glucose, L-glutamine, sodium
pyruvate, and 1% antibiotic antimycotic, for ≥ 20 min before use with seeding windows
(Mediatech Inc., Manassas, VA).
The extended sterilization and equilibration protocol for decellularized PITAS included
four steps. First, the scaffold was submerged in Betadine solution for 10 min with constant
agitation on an orbital shaker. Then, the scaffold was rinsed in sterile 1X PBS for 5 intervals of 5
min. Subsequently, each scaffold piece was transferred to an individual 50mL conical tube and
rinsed in ≥ 30mL of sterile 1X PBS for 5 intervals of ≥ 2 h (including one overnight ≥ 8 h rinse).
Scaffold sections were then transferred to Corning® DMEM [+] 4.5 g/L glucose, L-glutamine,
sodium pyruvate, and 1% antibiotic antimycotic, for ≥ 20 min for equilibration before use with
seeding windows (Mediatech Inc., Manassas, VA).
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2.3 Cytotoxicity Testing
The cytotoxicity of decellularized PITAS was evaluated utilizing established cell culture,
scaffold sterilization, and scaffold equilibration methods in two separate trials. In brief, Falcon®
6-well clear flat bottom TC-treated multiwell cell culture plates (product number 353046) were
seeded with 400,000 endothelial cells per well and incubated for 1 h allowing for cellular
attachment to the plate. Scaffolds decellularized in the 3% SDS/SDC condition were sterilized
and equilibrated according to either the standard protocol (trial 1) or the extended protocol (trial
2). These scaffolds were then partitioned into 5mm (± 1mm) squares using a sterile scalpel.
Scaffold sections were subsequently added to the 6-well plates in a serially increasing manner – 0
scaffold sections were added to well 1, 1 section was added to well 2, 2 sections were added to
well 3, and so on (Figure 2). These plates were then allowed to incubate for two days. Cell
viability was measured using the alamarBlue® assay at the 24 h and 48 h marks. Phase-contrast
images of cells in each condition were collected at the same intervals. The relative fluorescence
of the collected alamarBlue® samples were evaluated in a 96-well plate reader with excitation
and emission wavelengths of 560nm and 590nm, respectively. Images captured with the phasecontrast microscope were qualitatively analyzed through visual inspection – each image was
inspected for the relative prevalence of detached endothelial cells.
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Figure 2: The distribution of PITAS sections between wells used for cytotoxicity trails. Each
well of the culture plate was seeded with 400,000 endothelial cells. PITAS sections were then added
to each cell-seeded well in an N + 1 manner where N = the number of scaffold sections in the
proceeding well.
2.4 Silicone Seeding Window Construction
Silicone seeding windows were constructed by cutting individual seeding window pieces
from a single sheet of 3mm thick silicone. These pieces were cut to size by hand using a scalpel,
and all measurements were taken with a generic Vernier scale. The final exterior dimensions of
these seeding window components were 38mm x 28mm ± 2mm. Each silicone seeding window
also included a central cutout 10mm x 10mm ±4mm and 8 notches (2 on each side) to facilitate
scaffold access and banding for window stability (Figure 3).
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Figure 3: The construction of silicone seeding windows from bulk silicone sheets. (A) The main
body of the seeding window piece is cut from the larger sheet. (B) The central window is cut to
facilitate access to the scaffold once the seeding window is loaded. (C) Eight notches are cut from
the edges of the seeding window to enable the banding of seeding window pieces during scaffold
loading.
2.5 Standard Seeding Window Sterilization
All seeding window pieces (regardless of window construction material) were subjected
to a thorough standardized sterilization protocol. In brief, the window pieces were washed in dish
soap, rinsed in tap water, placed into a beaker, sprayed liberally with 70% isopropyl alcohol, and
transferred into a biosafety cabinet. There, the components were transferred via sterile forceps to
sterile dishware. Pieces within the dishware were then fully submerged in 10% bleach made with
sterile filtered water and subjected to 20 min of soak time under UV light with agitation on an
orbital shaker. Next, the bleach was aspirated and the windows were subjected to two 20 min
rounds of submersion in sterile filtered 70% EtOH with agitation on an orbital shaker while again
being subjected to UV light. Following these steps, the windows were then rinsed in sterile 1X
PBS (Corning®) for 3 intervals of 5 min with agitation on an orbital shaker. These sterilized and
rinsed windows were then equilibrated in Corning® DMEM [+] 4.5 g/L glucose, L-glutamine,
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sodium pyruvate, and 1% antibiotic antimycotic, for ≥ 20 min before use with scaffolds
(Mediatech Inc., Manassas, VA). Elastomer bands, used for securing the two halves of the
seeding window around the scaffold, accompanied the seeding window components through the
sterilization and equilibration process and are thereby prepared for later use in tandem with the
seeding windows.

2.6 Scaffold Mounting and Seeding – Silicone Seeding Windows
Upon completion of sterilization and equilibration protocols, silicone seeding windows
and scaffold material were interfaced to create the silicone seeding apparatuses (Figure 4). The
scaffold material was “sandwiched” within the seeding window pieces and secured with rubber
bands such that a central portion of the luminal side of each scaffold was oriented upward.
Thermo Fischer Scientific™ Nunc™ cell-culture treated multidishes (catalogue number 167064)
were then pre-loaded with 1mL of endothelial media. Individual assembled seeding apparatuses
were then transferred to the media loaded multi-well dishes. There, endothelial cells were loaded
onto the scaffold within the seeding window in a drop-wise manner (£ 0.5mL cellular media per
window). Cells were suspended within the dropped media at a concentration of 1x10^6 cells per
mL.
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Figure 4: Seeding apparatus preparation. (A) Silicone seeding windows and rubber bands are
prepared through standard sterilization and equilibration protocols. (B) Decellularized porcine
internal thoracic artery in native form. (C) Decellularized arteries are sectioned into seeding
appropriate conformation, sterilized, and equilibrated. (D) Sectioned scaffold is placed into the
seeding window apparatus. (E) The scaffold is secured within the seeding window using a top sheet
of silicone and rubber bands. (F) Assembled seeding windows are situated within multi-well culture
plates, loaded with cells, and incubated to facilitate recellularization.
2.7 3D Printed Seeding Window Design, Printing, and Post Print Processing
All 3D printed seeding windows were engineered in Tinkercad’s public online design
software (Autodesk, San Rafael, CA). Each seeding window consisted of two separate pieces
which, when assembled together, comprised a single seeding window unit. The exterior
dimensions of each assembled seeding window unit were 38mm x 28mm x 6mm. Each unit also
included a centrally located seeding well that was 10mm x 10mm and that passes through both
pieces of the assembled frame. The top piece of each seeding window was distinguishable by a
centrally raised section which measured 19.8mm x 19.8mm x 1mm and protruded below the plain
of the main interfacing surface of the piece. Conversely, the bottom piece of each seeding
window contained a central 20mm x 20mm x 1mm indentation. The distinct design of top and
bottom components allowed for a precise interface of pieces that defied horizontal rotation and
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facilitated the use of ≥ 0.4ml of growth media in the well created by the assembly of scaffold
within a seeding window. Each piece of the seeding window also included two notches along
each of their long edges. These were purposed to securely align the elastomer bands used to hold
the halves of the seeding window together around the scaffold during the seeding process (Figure
5). The seeding window design files were exported in .STL file format to be printed on either a
Fashfordge Creator Pro printer (for ABS and PLA version of seeding windows) or a Formlabs
Form 3 printer (for seeding window iterations utilizing Formlabs proprietary Dental Surgical
Guide Resin) (Flashforge USA, City of Industry, CA; Formlabs USA, Somerville, MA). After
printing, ABS and PLA seeding window components were broken free of their print supports and
then advanced directly to the seeding window sterilization and equilibration protocol previously
outlined. Resin based seeding windows required additional post processing before sterilization.
Post processing included extensive isopropyl alcohol rinses and direct exposure to UV light for
curation. These steps are recommended by Formlabs and ensure the full structural and chemical
integrity of the print resin. Further post processing steps for resin based seeding windows
included the removal of the individual seeding window pieces from their print support structures
and filing any abnormal surface deviations back into the desired plane. Following the additional
post processing steps, resin based seeding windows were also sterilized and equilibrated as
previously outlined in the standard protocol.
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Figure 5: The 3D printed seeding window design. (A) A top-down view of both halves of the
seeding window unit and general display of their features (B) The seeding window components
viewed from an angle to accentuate the features of the scaffold retention area. The bottom half of
the seeding window (red) features a 20mm x 20mm x 1.5mm recessed area designed to accept and
hold a sectioned piece of scaffold material. The top half of the seeding window (yellow) features a
complimentary 20mm x 20mm x 1.5mm protrusion that serves to hold the sectioned scaffold firmly
within the other half’s recessed area and to hold the two halves in alignment. (C) The two halves
of the seeding window oriented for interface. (D) The two halves of the seeding window interfaced
identically to their position when used to mount scaffold.
2.8 Seeding Window Biocompatibility Testing
Silicone and 3D printed seeding windows were evaluated for their biocompatibility.
Tissue culture dishes (n = 6) were prepared with equivalent numbers of endothelial cells and
allowed to incubate for 24 h. Seeding windows (silicone = 2, 3D printed ABS = 2, 3D printed
PLA = 2) sterilized and equilibrated according to our lab’s standard protocol were then added to
the endothelialized culture plates and incubated for 24 hours. At the conclusion of this interval, a
one-hour alamarBlue® viability assay was completed and samples collected for fluorescent
analysis. Phase-contrast microscope images of cells within each condition were also captured to
record cell morphology and confluence.
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2.9 Scaffold Mounting and Seeding – 3D Printed Seeding Windows
Upon completion of the 3D printed seeding window fabrication, post processing,
sterilization, and equilibration, assembly of the seeding apparatus was commenced. This
processes mirrored the protocol used for the assembly of silicone seeding apparatuses. Once the
seeding apparatuses were assembled and placed within the media preloaded multi-well culture
plates, 0.3mL of endothelial media, cellularized at a concentration of 1x10^6 cells per mL, was
drop-seeded onto the luminal side of the scaffold exposed within the seeding windows.
Subsequently, these cellularized seeding apparatuses were placed within the incubator on an
orbital shaker where they were agitated at ~ 50rpm on an orbital shaker for 2 h. At the completion
of this interval, the orbital shaker was turned off. The seeded scaffolds were then incubated in
static conditions for an additional 10 h. At the conclusion of this incubation period, the scaffolds
were removed from their individual seeding window apparatuses and placed in separate wells of a
6-well cell culture plate. Each well containing a cellularized scaffold was then filled with 4mL of
endothelial media and placed back within the incubator for 7 days after the initial seeding event.

2.10 Scaffold Cellularity Gating via Metabolic Analysis
At the conclusion of the 7 day incubation, the cellularized scaffolds were screened for
cellularity using culture medium containing alamarBlue® reagent. Scaffolds were transferred
from the 6-well plates in which their primary incubation occurred and placed into individual wells
of a 12-well plate. Each scaffold was submerged in 1.5mL of alamarBlue® supplemented growth
media and allowed to react. Cells will metabolize/reduce the resazurin present in the
alamarBlue™ into the fluorescently active resorufin. The progression of this reaction can be
quantified in terms of relative fluorescent units (RFUs) and can also observed as a visual change
in color from blue to pink (Figure 6). These indications serve as suitable proxies for cellular
activity and health that is both immediately readable through qualitative judgements and scrutable
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through quantifiable measures. alamarBlue samples collected from cellular gating trials were
evaluated in a 96-well plate reader with excitation and emission wavelengths of 560nm and
590nm, respectively. These data were then compiled by trial number and scaffold
decellularization detergent condition group and statistically evaluated.

Figure 6: Scaffold cellularity screening through alamarBlue®. Wells 1-3 all show scaffold with
cellularized area (pink) surrounded by a non-cellular margin (blue). This indication of cellularity
can be used to determine if individual scaffolds are then advanced through downstream staining
and imaging protocols. Additionally, alamarBlue® supplemented media can be collected from each
scaffold containing well and held for additional quantitative fluorescent analysis.
2.11 Scaffold Staining and Fluorescent Microscope Imaging
Scaffolds were prepared for imaging through an adapted Phalloidin and Hoechst staining
protocol. In short, PITAS were rinsed in sterile 1X PBS after being run through the alamarBlue®
cellular gating protocol. Scaffolds were then fixed in 4% paraformaldehyde for 1 hour before
being rinsed in sterile 1X PBS. These fixed and rinsed scaffolds were then permeabilized in 0.1%
Triton X-100 for 5 minutes. After this interval, the scaffolds were again rinsed in sterile 1X PBS
before being stained with Phalloidin-CruzFlour594 and Hoechst 33342 to visualize actin
filaments and nuclei, respectively. At the conclusion of staining, scaffolds were rinsed and stored
in sterile 1X PBS.

17

Stained PITAS were imaged using an Olympus CKX-41 inverted fluorescent microscope.
Scaffolds were wet mounted face down on a glass slide. Images were captured according to two
methods. First, the most densely cellularized area of the scaffolds were imaged with the 20X
objective. Independent fields of view were imaged (n = 4-10 per scaffold) loosely following a
serpentine pattern of image capture (Figure 7). The average number of cells per field of view was
then calculated using Hoechst stained nuclei counts to approximate cell density (Figure 8).
Second, whole scaffolds were scanned using the 10X objective, and the number of independent
fields of view containing ≥ 20 distinguishable Hoechst stained nuclei were counted. This number
was then divided by the total independent fields of view per scaffold to determine the general
scaffold cellularity. These data were then compiled by scaffold decellularization detergent
condition group and statistically evaluated.

Figure 7: Fluorescent microscopy image capture pattern.
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Figure 8: Nuclei counts from independent fields of view used to calculate cell density. After
locating cells on seeded scaffolds, images were captured using the 20X objective. As many
images were captured from each sample as there were independent fields of view (n=4-10). Each
image was then evaluated for the number of distinguishable nuclei it contained. Representative
images from each decellularization detergent condition are demarcated in the upper left of each
panel.
2.12 Ultrastructure Evaluation through Scanning Electron Microscopy
The ultrastructure of PITAS prepared in each decellularization condition (control/PBS,
0.5% SDS/SDC, 1% SDS/SDC, 1.5% SDS/SDC, and 3% SDS/SDC) were analyzed via scanning
electron microscopy (SEM) on a JEOL 1610-LA Scanning Electron Microscope. PITAS were
cross-sectioned and prepared for SEM imaging according to a protocol adapted for our lab
(Figure 9). First, scaffolds were sectioned into ~ 5mm pieces. Then the pieces were fixated in
McDowell Trump fixative for 2 hours. After extensive rinsing in PBS and ultrapure water, the
scaffold sections were then progressed through an ethanol dehydration protocol starting with 35%
EtOH and ending with 100% EtOH. Scaffolds were then immersed in fresh HMDS twice before
being decanted in HDMS overnight. Finally, scaffolds were mounted to SEM stages and gold
sputter coated. Two representative areas from each scaffold were image captured from opposite
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sides of each scaffold at magnifications of 50X, 100X, 150X, 250X, and 500X. These images
were then qualitatively analyzed to determine variance in porosity.

Figure 9: A visual representation of the SEM preparation protocol used for PITAS. (A) 5mm
of PITA was sectioned from scaffolds from each decellularization condition. (B) Scaffold sections
were prepared for SEM imaging through fixation, EtOH and HDMS dehydration, and then mounted
and gold sputter-coated. (C) Two areas (indicated by blue arrows) on each scaffold were image
captured at progressively increasing magnifications.
2.13 Statistical Analysis
All statistical tests were completed using IBM’s SPSS software (IBM, Armonk, NY). To
test seeding window biocompatibility, a Brown-Forsythe test was employed. All data from
seeding trials were tested with scaffold decellularization detergent condition (control/PBS, 0.5%
SDS/SDC, 1% SDS/SDC, 1.5% SDS/SDC, and 3% SDS/SDC) as the independent variable. The
dependent variables (number of nuclei per independent field of view, percent independent fields
of view with ≥ 20 distinguishable nuclei, and RFU) were evaluated in separate Kruskal-Wallis
tests and subsequently assessed via linear regression. All tests were run using a 0.05 level of
significance.
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Results
3.1 Scaffold Cytotoxicity
To determine if scaffold sterilization and equilibration protocol had an observable effect
on cellular viability, endothelial cells were incubated with scaffold sections prepared according to
both the standard and extended PITA sterilization and equilibration protocols. Cells are in direct
contact with the PITAS during the entire seeding process. Therefore, the maximization of cellular
viability in the presence of PITAS is vital to the success of the scaffolds eventual
recellularization. The viability of cells incubated with PITAS prepared according to the standard
protocol were negatively influenced by the scaffolds’ presence as qualitatively demonstrated in
Figure 10A. There, cells can be seen fully confluent in the top left panel where scaffold was not
present during incubation. However, as the dosage of scaffold pieces increased, the endothelial
cells can be seen demonstrating progressively less confluent. The bottom right panel of figure
10A represents cells exposed to the maximum number of scaffold sections sterilized according to
the standard protocol – under those conditions cells were completely inviable. This observation
(that of dose dependent cytotoxicity) was quantified through an alamarBlue® cellular metabolism
assay which further showed scaffolds sterilized and equilibrated according to the standard
protocol to have cytotoxic effects detrimental to cell viability (Figure 10B). Though cells appear
tolerant of small doses of scaffold exposure, they were evidently unable to withstand the higher
concentrations of cytotoxicity produced by incubation with ³ 3 scaffold sections present in the
culture plate well. Conversely, scaffold prepared according to the extended sterilization and
equilibration protocol did not appear to affect the viability of cells. Cellular metabolism in the
extended protocol group remained consistently viable regardless of number of scaffold sections
added to each culture plate well.

21

Figure 10: The impact of scaffold sterilization and equilibration procedures on cellular
viability. (A) Phase-contrast images of endothelial cells contained within individual culture dish
wells from a standard sterilization and equilibration scaffold trial. Numbers indicate the number of
scaffold pieces contained within that well. (B) Cellular viability in the presence of an increasing
number of scaffold pieces assayed using alamarBlue® and expressed as percent relative change in
RFU from control at 24 and 48 hours (n=1).
3.2 Seeding Window Biocompatibility
To measure the effect of seeding window construction material on cellular viability,
plates of endothelial cells were incubated in the presence of seeding windows constructed from
silicone, printed ABS, and printed PLA. Cells are in direct contact with seeding windows during
the first 12 h of the seeding process. As such, the maximization of cellular viability in the
presence of seeding windows is fundamental to the success of the eventual recellularization of the
scaffold each seeding window contains. The observed endothelial cell morphology between
groups did not suggest differences in biocompatibility. Additionally, alamarBlue® data collected
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from the biocompatibility trials suggested that the mean RFU between groups (Silicone, ABS,
and PLA) did not significantly differ (p=0.223) (Figure 11).
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Figure 11: Seeding window material does not affect biocompatibility. Endothelial cells were
cultured in the presence of seeding windows made from silicone, printed ABS, and printed PLA
for 24h. Cellular viability was measured at the end of this interval using the alamarBlue assay.
Means were evaluated via the Brown-Forsythe test for the equality of group variances: F=7.853,
DF=2, p=0.223) Error bars are +/- standard error of the mean (n=2).
3.3 Metabolic Analysis of Recellularized Scaffolds
To determine effect of scaffold decellularization detergent condition on the cellular
metabolism of seeded PITAS (metabolism being used as a proxy for number of living cells
repopulating the scaffold), each seeded scaffold was incubated as part of an alamarBlue® assay
after 7 days of culture. The results of these assays were quantified in terms of RFU and
scrutinized percent change from their individual trials’ negative control to better facilitate
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comparison between trials. This data was assessed via Kruskal-Wallis evaluation of groups and
linear regressions tests. No significant difference in cellular metabolism was found between
scaffold decellularization detergent condition groups (p=0.531) (Figure 12). However,
decellularization detergent condition was found to be a strong predictor of metabolic variance
(R2=0.911). The concentration of the scaffold decellularization detergent condition is positively
correlated with the seeded scaffolds’ metabolic activity. This result was consistent across

RFU Percent Change From Control

independent trials (Figure 13).
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Figure 12: Decellularization detergent concentration does not have a significant effect on the
metabolic activity of seeded scaffolds. alamarBlue® assays were conducted with each of the
cellularized PITAS at the conclusion of their seeding protocols. These results were quantified in
RFU and compared against each trial’s negative control. No statistically significant difference
between groups was revealed (Kruskal-Wallis: H=3.164, DF= 4, Sig. = 0.531) Error bars are +/standard error of the mean (n=2).
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Figure 13: Scaffold decellularization detergent concentration is positively correlated with
seeded scaffold metabolic activity. alamarBlue® assays were conducted with each of the
recellularized PITAS at the conclusion of their seeding protocols. These results were quantified in
RFU and normalized to each trial’s negative control. Linear regression analysis of each trial
revealed a strong positive correlation between scaffold decellularization detergent condition and
seeded scaffold metabolic activity. Trial 1 R2=0.881 (F-ratio=22.243, DF=1,3, p=0.018), Trial 2
R2=0.842 (F-ratio=16.039, DF=1,3, p=0.028), Mean Trials 1 & 2 R2=0.911 (F-ratio=30.643,
DF=1,3, p=0.012). (n=2)
3.4 Cellularity as Determined by Fluorescent Microscope Imaging
To test the relationship between scaffold decellularization detergent condition and the
cell density of seeded PITAS, each scaffold was imaged using Hoechst stain and fluorescent
microscopy. The cell density of each scaffold was defined as the average number of nuclei
observed within each independent field of view (FOV) contained within the most densely
cellularized area of each scaffold. Mean cellular densities were significantly divergent between
groups (p=0.001). Post hoc pairwise comparisons showed these significant differences in
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cellularity were between 0.05% detergent and 1.5% detergent condition groups (p=0.005) and
between 1% and 1.5% detergent condition groups (p=0.001). (Figure 14). Linear regression
analysis showed that the concentration of the scaffold decellularization detergent condition was
positively correlated with cellular density in the first trial R2=0.632 (p=0.000). However, the
second trial did not exhibit a similar relationship (p=0.261). Combining data from trials 1 & 2
weakened the linear relationship between scaffold decellularization detergent condition and
cellular density to R2=0.182 (p=0.000) (Figure 15).
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Figure 14: Decellularization detergent concentration affects the density of cells in
recellularized scaffolds. Hoechst staining and fluorescent microscopy were completed for seeded
PITAS. Cellularity was determined by the average number of nuclei counted in each independent
FOV. Cellularity significantly differed between groups (Kruskal-Wallis: H=17.618, DF=4,
p=0.001). Pairwise comparisons showed differences in cellularity between 0.05% and 1.5%
detergent condition groups (p=0.005) and between 1% and 1.5% detergent condition groups
(p=0.001). Error bars are +/- standard error of the mean (n=4-10).
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Figure 15: Scaffold decellularization detergent concentration is positively correlated with
scaffold cellularity in trial 1. Hoechst staining and fluorescent microscopy were completed for
seeded PITAS. Cellularity was determined by the average number of nuclei counted in each
independent FOV. Linear regression analysis of each trial revealed a positive correlation between
scaffold decellularization detergent condition and seeded scaffold cellularity in trial 1 R2=0.632 (Fratio=65.313, DF=1,38, p=0.000). Trial 2 did not demonstrate a correlation (p=0.261). Combined
data from trials 1 & 2 showed a weak relationship between detergent condition and cellularity
R2=0.182 (F-ratio=16.931, DF=1,76, p=0,000). (n=2)
To investigate the relationship between scaffold decellularization detergent condition and
the general cellularity of the PITAS, whole scaffolds were imaged utilizing Hoechst stain and
fluorescent microscopy, and the percentage of FOV containing ≥ 20 distinguishable nuclei was
calculated. From this, it was determined that cellularity was not significantly different between
groups (p=0.314) (Figure 16). Further, linear regression analysis did not reveal any significant
relationships; trial 1 (p=0.183), trial 2 (p=0.457), mean trials 1 & 2 (p=0.099) (Figure 17).
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Figure 16: Decellularization detergent concentration does not affect the general cellularity of
recellularized scaffold. Hoechst staining and fluorescent microscopy were completed for seeded
PITAS. Cellularity was determined by the percentage of FOV containing ≥ 20 distinguishable
nuclei. Insufficient evidence was found to conclude a significant difference in cellularity between
groups (Kruskal-Wallis: H=4.747, DF=4, p=0.314). Error bars are +/- standard error of the mean
(n=2).
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Figure 17: Scaffold decellularization detergent condition does not correlated with PITAS
cellularity. Hoechst staining and fluorescent microscopy was completed for seeded PITAS.
Cellularity was determined by the percentage of FOV containing ≥ 20 distinguishable nuclei.
Linear regression analysis did not reveal any relationship between scaffold decellularization
condition and scaffold percent cellularity. Trial 1 (p=0.183), trial 2 (p=0.457), mean – trials 1 & 2
(p=0.099) (n=2).
3.5 SEM Ultrastructure Evaluation
In order to elucidate the influence of scaffold decellularization detergent condition on the
ultrastructure of PITAS, extensive SEM analysis was completed. A total of 18 unique PITAS
were cross-sectionally imaged at two locations and at five magnifications. Porosity between
scaffolds was inconsistently qualitatively different between those decellularized at varying
detergent concentrations. However, this finding was not as reliable as the stark differences in
porosity evident between non-decellularized PITAS prepared in PBS solution and those which
were decellularized in 1.5% or 3% detergent conditions (Figure 18).
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Figure 18: Qualitative differences in porosity are observable between scaffold
decellularization detergent groups. Evaluation of scaffold ultrastructure was completed via SEM.
Magnifications are organized in columns – 50X, 100X, 150X, 250X and 500X. Each row represents
a different decellularization detergent condition – PBS, 0%, 0.5%, 1%, 1.5%, and 3%. The most
evident differences in porosity can be observed between the PBS group and the 1.5% and 3%
detergent groups respectively.
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Discussion
4.1 Scaffold Cytotoxicity Results Discussion
Chemical based decellularization techniques, such as those used by our collaborators at
the University of South Carolina School of Medicine, require the use of cytotoxic agents – it is
necessary that cells be substantially disrupted in order to remove them from their extracellular
matrix. The data from our scaffold cytotoxicity tests strongly suggest that cytotoxic levels of
residual decellularization detergent within PITAS could withstand the standard scaffold
sterilization and equilibration protocol. Conversely, those PITAS subjected to an extended
protocol did not exert any cytotoxic effects. Importantly, the extended protocol group never
exhibited a reduction in cellular metabolism at either the 24 h or 48 h time period (Figure 9B).
The key factor differentiating the standard and extended protocols is the number and
duration of PBS rinses each scaffold was subjected to. Extended exposure to an environment
hypotonic to the detergent within the PITAS proved effective for maintaining cellular viability
across scaffold dosages and across time suggesting the scaffolds are made fully biocompatible by
the process. This biocompatibility is a necessary prerequisite for the construction of a
recellularized scaffold since the PITAS are in direct contact with endothelial cells for the entire
duration of the seeding process and incubation.

4.2 Seeding Window Biocompatibility Results Discussion
The seeding windows used for scaffold recellularization are a second component in direct
contact with cells during the initial seeding event. Therefore, their biocompatibility is of primary
importance as well. Previous seeding trials in our lab had successfully utilized silicone seeding
windows (data not shown). However, silicone seeding windows, constructed according to our
best available methods, have inherent disadvantages. Primarily, their construction is reliant upon
hand measurements, which result in variations in seeding well area between seeding windows
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(Figure 3). This limits their utility for controlled trials that rely on consistent conditions across
groups. Out of this need for consistency, the design for 3D printed seeding windows was ideated.
3D printing seeding windows allows for consistent seeding window dimensions across an infinite
number of samples. However, the biocompatibility of ABS and PLA filaments printed in our lab
was unproven in cell culture applications. The results of our seeding window biocompatibility test
demonstrated that neither ABS nor PLA filament seeding windows significantly differed in their
cellular compatibility from the silicone constructed seeding windows. Nevertheless, the intrinsic
porosity of filament based 3D prints made the use of ABS and PLA seeding windows untenable
due to their inability to be dependably sterilized (data not shown). Therefore, resin based 3D
printed seeding windows were ultimately selected for the seeding trials from which all metabolic
and cellularity data was derived. These differ substantially from their ABS and PLA filament
based seeding windows counterparts because their structure is inherently nonporous and therefore
more reliably sterilizable. A separate biocompatibility trial was not conducted for resin based
seeding windows because their biocompatibility had been previously established by the resin
manufacture (Formlabs USA, Somerville, MA).

4.3 Metabolic Analysis Results Discussion
PITAS’ cellular metabolism does not significantly differ between scaffold
decellularization detergent groups as assessed via alamarBlue® assays (Figure 11). This
observation is made curious by the fact that these same metabolic assays revealed a statistically
significant positive correlation between scaffold decellularization detergent concentration and the
cellular metabolism of seeded PITAS (Figure 12). The most likely explanation for this seeming
discrepancy in results is the limited sample size afforded by the scope of our work. Given the
predictive value of scaffold decellularization detergent concentration for anticipating variability
in reendothelialized scaffold metabolism (R2=0.911) it is reasonable to expect that additional
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trials could serve to increase the resolution of the data and possibly reveal a statistically
significant cellular metabolism between groups if such a difference does indeed exist.
A further implication of this testing is that endothelial cells established on PITAS
according to our protocol are not only present but metabolically functional. This indicates that our
seeding materials and methodologies are effective for both establishing endothelial cell presence
and preserving cellular viability. This is a prerequisite to the design of an effective tissue
engineered vascular solution, which requires living cells so that it may eventually integrate as a
living tissue within its recipient.

4.4 Cellularity as Determined by Fluorescent Microscope Imaging
In order to achieve the ultimate goal of any vascular tissue engineering project (to make a
viable vascular tissue) a central functional component of vasculature tissues must be replicated –
the tunica intima. This layer consists of a single sheet of endothelial cells. Imitating this layer of a
blood vessel requires the establishment of a confluent expanse of endothelial cells over the
entirety of the venous or arterial luminal surface. To this end, our work evaluating PITAS via
fluorescent microscopy lays the foundations for determining the most effective scaffold
decellularization detergent concentration conditions to promote the establishment of a confluent
endothelial layer.
The differences in cellular densities between decellularization detergent concentration
groups (Figure 13) suggest that an ideal condition exists for the promotion of maximum cellular
density (confluence). The combined results of both Kruskal-Wallis and linear regression analysis
of cellular densities indicate that higher concentrations of decellularizing agent are associated
with increased cellular densities. Though significant differences in cellular densities between
groups only manifested between 0.05% and 1.5% and 1% and 1.5% detergent concentration
groups (p=0.005 and p=0.001 respectively), the mean cellular density of the 3% detergent
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concentration group, and the trend of the linear regression from trial one (Figure 12), suggests
that the 3% detergent concentration may be the best suited for promoting cellular density. This is
observation is corroborated by the data collected from seeded PITAS metabolic analysis which
also suggests a strong positive relationship between decellularization detergent concentration and
number of cells present on the scaffold.
The finding that the general cellularity of seeded PITAS did not significantly differ
between decellularization detergent concentration groups (Figure 13) is not unexpected. Each
PITA scaffold was seeded in identical conditions. Importantly, all seeding windows exposed an
identical amount of scaffold area, 1cm2, to endothelial cells during the seeding protocol. Thereby,
the similarity of cellularized scaffold area across groups can be easily accounted for. Insignificant
differentiations in general cellularity between groups is most likely an artifact of imprecise
methodology. Specifically, the exterior dimensions of PITAS was not tightly controlled (the
inclusion criteria was dimensions of ≥ 15mm x 15mm and did not include a maximum dimension
exclusion criteria). As such, it can be concluded that, because cellularity was calculated by
determining the percentage of FOV with ≥ 20 distinguishable nuclei, variations in the scaffold
area not exposed to cells within the seeding window changed the denominator of cellularity
calculated such as to cause insignificant variations in calculated cellularity between groups.

4.5 SEM Ultrastructure Evaluation Results Discussion
The insignificant variations observed in the ultrastructure between detergent
concentration groups of decellularized PITAS is supported by the findings of our research
collaborator, Dr. Wayne Carver, at the University of South Carolina School of Medicine. His lab
has found that the composition of decellularized PITAS is generally equivalent between
decellularization detergent concentration groups (data not shown). However, both our labs have
observed that some differences are detectable. Especially between those groups decellularized in
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the highest and lowest concentrations of detergent. Further, the delineation between negative
controls (PBS decellularized) and detergent decellularized is clear.

4.6 Novel Innovations
The development and proved efficacy of 3D printed seeding windows represents the most
significant innovation of this research. To the best of my knowledge, this project is the first tissue
engineering venture to incorporate 3D printed resin based seeding windows based on Formlabs’
proprietary Dental Surgical Guide Resin (Formlabs USA, Somerville, MA). This material proved
durable, sterilizable, and economical. Broadly, 3D printed seeding windows have multiple
advantages for recellularizing sheet-like biomaterials. First, their dimensions are easily tailored to
the needs of whatever biological scaffold is being seeded. An infinite number of dimensional
changes can be made to affect the desired seeding environment outcome. These changes include
dimensional alterations to the seeding well, variations to the seeding windows shape, and
alterations in the scaffold-window interface, all of which can be optimized to the specific needs of
the project at hand. Second, the design of these seeding windows has been intentionally crafted
such that both sides of the scaffold are accessible when mounted within the window. Though
endothelial seeding of PITAS’ luminal surface was the focus of this study, future trials will need
to characterize effective seeding protocols for the adventitial surface with smooth muscle cells;
smooth muscle cells are an integral component of blood vessel structure. Further, the creation of
3D printed seeding windows is economical. Design software is available through open access
software such as Auto desk’s TinkerCad (San Rafael, CA). 3D printer capabilities are available at
most universities and individual print costs are extremely affordable (individual seeding window
components can cost as little as $0.18 each). Finally, 3D printable seeding window design files
can be easily shared between collaborators through the simple transmission of an .STL file. For
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these reasons it I am hopeful that the seeding window innovations pioneered in this project will
find applications in future research.
An additional noteworthy innovation of this research is the use of alamarBlue® assays
for the evaluation of small tissue samples. alamarBlue®, an assay typically used for the metabolic
evaluation of cells, was here also used to give a visual indication of seeding protocol efficacy. In
this application the blue colored resazurin was allowed to permeate the cellularized tissue where
it was then converted by the cells within the tissue into the distinctly red resorufin. This made
cellularized areas of seeded PITAS easily visible to the naked eye (Figure 6). This qualitative
information could then be used to gate the decision of whether or not to use resources in
attempting to collect quantitative data from a particular sample. E.g. samples which failed to
exhibit a color change were not advanced to further testing. This type of gating step could help
improve the efficiency of future studies by affording researchers a rapid and effective method to
judge the efficacy of their seeding protocols. Furthermore, alamarBlue® is a non-toxic nonendpoint assay, meaning that researchers can utilize it to collect metabolic data from tissue
samples across multiple points of time without halting the culture of the cells within said sample.

4.7 Future Directions
This research provides evidence to suggest that PITA scaffold decellularization detergent
concentration does have an effect on scaffold reendothelialization. Further, our data indicate that
some detergent conditions may be better suited to the promotions of effective reendothelialization
than others. This detail oriented analysis of the interrelationship between these factors moves the
field of vascular tissue engineering forward towards the goal of a functional tissue replacement.
Specifically, it provides foundational data that can be used for future trials that seek to further
optimize the establishment of a confluent endothelial layer within a tissue engineered vessel. This
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should be a focus of future research, because, as previously stated, the creation of an operational
confluent tunica intima is imperative.
Though the reendothelialization of PITAS has herein been considered at length, another
component necessary for the creation of a viable tissue engineered blood vessel, smooth muscle
cells, has been absent from discussion. Our methodologies used for seeding and evaluating
endothelial cells could easily be applied to the analysis of decellularization detergent
concentration’s impacts on smooth muscle cells’ scaffold interactions. This research could yield
valuable information regarding the ideal detergent conditions to use for PITA decellularization
for eventual seeding trails that incorporate the coculture of both endothelial and smooth muscle
cells. Once optimized protocols have been established for seeding PITAS with both endothelial
and smooth muscle cells in coculture, additional work must be done to develop methodologies
adapted to facilitate the recellularization of scaffolds in their native cylindrical confirmations.

4.8 Research Limitations
The paramount limitation of this study is its truncated sample size. An increased number
of samples would have provided greater clarity as to the significance of observed trends.
Specifically, more data points may have allowed for the use of stronger parametric tools of
statistical analysis.
Another limitation includes an inability to control for the surface topography of PITAS.
The surface of PITAS varied between samples. These difference may have contributed to
deviations in cell distribution that could not be accounted for with a controlled seeding protocol.
Finally, thought the same cell line was used in both seeding trials, cells were collected at
different passage numbers. The first trial was seeded with P7 cells while the second was passaged
with P10 cells. Subtle differences between cells harvested from differing passages may have also
contributed to some system variability.
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4.9 Unproductive Methodologies Appendix
•

SEM imaging of the luminal surface of PITAS proved untenable. Scaffolds have a strong
tendency to change their conformation during the necessary SEM sample preparation
protocol. This results in asymmetrical samples too varied in their topography to be focused in
our microscope.

•

PITAS proved to be highly autofluorescent. This fluorescence overpowered the sensitivity of
our microscope to delineate GFP cell signatures and phalloidin stained cells.

•

Autoclave sterilization is not effective protocol for either ABS or PLA based seeding
windows. Though autoclaved filament based seeding windows were sterile after being
autoclaved, they did not retain their dimensions and failed to reliably interface as a unit after
this conformational change.

38

Literature Cited
Amiel GE, Komura M, Shapira O, Yoo JJ, Yazdani S, Berry J, Kaushal S, Bischoff J, Atala A,
Soker S. 2006. Engineering of blood vessels from acellular collagen matrices coated with
human endothelial cells. Tissue Engineering. 12 (8):2355-2365.
Andrée B, Bela K, Horvath T, Lux M, Ramm R, Venturini L, Ciubotaru A, Zweigerdt R,
Haverich A, Hilfiker A. 2014. Successful re-endothelialization of perfusable biological
vascularized matrix (BioVam) for the generation of 3D artificial cardiac tissue. Basic
Research in Cardiology [internet]. [cited 2019 Feb 20] 109:441. Available from:
https://doi.org/10.1007/s00395-014-0441-x
Badlyak SF, Freytes DO, Gilbert TW. 2009. Extracellular matrix as a biological scaffold
material: structure and function. Acta Biomaterialia [internet]. [cited 2019 Feb 16] 5:1-13.
Available from: doi:10.1016/j.actbio.2008.09.013
Benjamin et al. 2018. Heart disease and stroke statistics – 2018 update: a report from the
American heart association. Circulation [internet]. [cited 2018 Nov 19] 137:e67–e492.
Available from: https://doi.org/10.1161/CIR.0000000000000558
Celiikkin N, Rinoldi C, Costantini M, Trombetta M, Rainer A, ´Swięszkowski W. 2017.
Naturally derived proteins and glycosaminoglycan scaffolds for tissue engineering
applications. Material Science and Engineering C [internet]. [cited 2019 Jan 19] 78: 12771299. Available from: https://doi.org/10.1016/j.msec.2017.04.016
Crapo PM, Gilbert TW, Badlyak SF. 2011. An overview of tissue and whole organ
decellularization processes. Biomaterials [internet]. [cited 2019 May 19] 32(12): 3233-3243.
Available from: DOI:10.1016/j.biomaterials.2011.01.057
Dahan N, Sarig U, Bronshtein T, Baruch L, Karram T, Hoffman A, Machluf M. 2017. Dynamic
autologous reendothelialization of small-caliber arterial extracellular matrix: a preclinical
large animal study. Tissue Engineering [internet]. [cited 2019 Feb 23] 23:69-79. Available
from: DOI: 10.1089/ten.tea.2016.0126
Duan B, 2016. State-of-the-art review of 3D bioprinting for cardiovascular tissue engineering.
Annals of Biomedical Engineering. [internet]. [cited 2018 Nov 26] 45(1):195-209. Available
from: DOI:10.1007/s10439-016-1607-5
Hausenloy DJ, Yellon DM. 2013. Myocardial ischemia-reperfusion injury: a neglected
therapeutic target. Journal of Clinical Investigation [internet]. [cited 2018 Nov 13]
123(1):92-100. Available from: DOI:10.1172/JCI62874.
Kasimir MT, Rieder E, Seebacher G, Silberhumer G, Wolner E, Weigel G, Simon P. comparison
of different decellularization procedures of porcine heart valves. Int J Artif Organs
[internet]. [cited 2019 May 19] 26(5):421-427

39

Lichtenberg A, Tudorache I, Cebotari S, Ringes-Lichtenberg S, Sturz G, Hoeffler K, Hurscheler
C, Brandes G, Hilfiker A, Haverich A. 2006. In vitro re-endothelialization of detergent
decellularized heart valves under simulated physiological dynamic conditions. Biomaterials
[internet]. [cited 2019 Feb 10] 27:4221-4229. Available from:
doi:10.1016/j.biomaterials.2006.03.047
Meyer SR, Chiu B, Churchill TA, Zhu L, Lakey JRT, Ross, DB. 2006. Comparison of aortic
valve allograft decellularization techniques in the rat. Journal of Biomedical Materials
Research [internet]. [cited 2018 Sep 12] 79A:254-262. Available from: DOI:
10.1002/jbm.a.30777
Meyer SR, Nagendran J, Desai LS, Rayat G, Churchill TA, Anderson CC, Rajotte RV, Lakey
JRT, Ross DB. 2005. Decellularization reduces the immune response to aortic valve
allografts in the rat. Journal of Thoracic and Cardiovascular Surgery [internet]. [cited 2018
Sep 18] 130:469-76. Available from: doi:10.1016/j.jtcvs.2005.03.021
Seif-Naraghi SB. et al. 2013. Safety and efficacy of an injectable extracellular matrix hydrogel
for treating myocardial infarction. Science Translational Medicine [internet]. [cited 2019
Feb 23] 20: 5(173). Available from: doi:10.1126/scitranslmed.3005503.
Skalak R and Fox CF. 1993. Emergence and evolution of a shared concept. Abt Associates Inc.
Emergence of tissue engineering – Final report [internet]. [cited 2019 Feb 16] Available
from: https://www.nsf.gov/pubs/2004/nsf0450/emergence.htm
Song HHG, Rumm RT, Ozaki KC, Edelman ER, Chen CS. 2018. Vascular tissue engineering:
progress, challenges, and clinical promise. Cell Stem Cell [internet]. [cited 2018 Mar 1]
1;22(3):340-354. Available from: doi: 10.1016/j.stem.2018.02.009.
Sun X, Altalhi W, Nunes SS. 2015. Vascularization strategies of engineered tissues and their
cardiac regeneration. Advanced Drug Delivery Reviews [internet]. [cited 2018 Nov 13]
96:183-194. Available from: http://dx.doi.org/10.1016/j.addr.2015.06.001
United Nations, Department of Economic and Social Affairs, Population Division. 2017. World
Population Prospects: The 2017 Revision, Key Findings and Advance Tables [internet].
[cited 2019 Feb 19] Working Paper No. ESA/P/WP/248. Available from:
https://esa.un.org/unpd/wpp/Publications/Files/WPP2017_KeyFindings.pdf
Quinn RW, Hilbert SL, Converse GL, Bert AA, Buse E, Drake WB, Armstrong M, Moriarty SJ,
Lofland GK, Hopkins RA. 2011. Enhanced autologous re-endothelialization of
decellularized and extracellular matrix conditioned allografts implanted into the right
ventricular outflow tracts of juvenile sheep. Biomedical Engineering Society [internet].
[cited 2018 Sep 16] Available from: DOI: 10.1007/s13239-011-0078-y

